Wiley-Blackwell, the STM and scholarly publishing business of John Wiley & Sons, Inc., US, has announced the launch of Cancer Medicine, a new Wiley Open Access journal.
Cancer Medicine is a peer reviewed, open access, interdisciplinary journal providing rapid publication of cutting edge research from global biomedical and clinical researchers across all the oncologic specialties in cancer biology, clinical cancer research and cancer prevention. The journal's promise of full global reach is reinforced by its editorial leadership and support from prestigious journals and societies. It is supported by three major cancer societies - American Cancer Society (ACS), Union for International Cancer Control (UICC) and Japanese Cancer Association (JCA).
Cancer Medicine is steered by Editor-in-Chief Dr. Qingyi Wei, a highly published and cited author based at the world's leading cancer research center in the US. Dr. Wei's previous editorial work includes a role as a Senior Editor on the American Association for Cancer Research's journal, Cancer Epidemiology, Biomarkers & Prevention. His research is aimed at identifying individuals at high risk of developing cancer.
The journal is currently open to submissions and aims to publish its first content online in Spring 2012.
Search for more Oncology related STM journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
